Shweta Urva

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 18

Top Topics

Drug Administration

Top Venues

CPT: pharmacometrics & systems pharmacology

Current medical research and opinion

Diabetes, obesity & metabolism

Clinical pharmacokinetics

This page only lists publications with an associated author ORCID identifier.

Publications

Karen Schneck, Shweta Urva
Population pharmacokinetics of the GIP/GLP receptor agonist tirzepatide. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Karen Schneck, Shweta Urva
Population pharmacokinetics of the GIP/GLP receptor agonist tirzepatide. CPT: pharmacometrics & systems pharmacology (2024)
Shweta Urva, Joshua A Levine, Karen Schneck, Cheng Cai Tang
Model-based simulation of glycaemic effect and body weight loss when switching from semaglutide or dulaglutide to once weekly tirzepatide. Current medical research and opinion 40 (4) (2024)
Shweta Urva, Joshua A Levine, Karen Schneck, Cheng Cai Tang
Model-based simulation of glycaemic effect and body weight loss when switching from semaglutide or dulaglutide to once weekly tirzepatide. Current medical research and opinion 40 (4) (2024)
Karen Schneck, Shweta Urva
Population pharmacokinetics of the GIP/GLP receptor agonist tirzepatide. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Karen Schneck, Shweta Urva
Population pharmacokinetics of the GIP/GLP receptor agonist tirzepatide. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Shweta Urva, Joshua A Levine, Karen Schneck, Cheng Cai Tang
Model-based simulation of glycaemic effect and body weight loss when switching from semaglutide or dulaglutide to once weekly tirzepatide. Current medical research and opinion 40 (4) (2024)
Aarti Sawant-Basak, Shweta Urva, Jatinder Kaur Mukker, Sebastian Haertter, Dean Mariano, Dolly A Parasrampuria, Kosalaram Goteti, Ravi Shankar Prasad Singh, Manoj S Chiney, Michael Z Liao, Sandy S Chang, Rashmi Mehta
Role of Clinical Pharmacology in Diversity and Inclusion in Global Drug Development: Current Practices and Industry Perspectives: White Paper. Clinical pharmacology and therapeutics (2024)
Shweta Urva, Joshua A Levine, Karen Schneck, Cheng Cai Tang
Model-based simulation of glycaemic effect and body weight loss when switching from semaglutide or dulaglutide to once weekly tirzepatide. Current medical research and opinion (2024)
Filip K Krag Knop, Shweta Urva, Mallikarjuna Rettiganti, Charles T Benson, William C Roell, Kieren J Mather, Axel Haupt, Edward John Pratt
A long-acting glucose-dependent insulinotropic polypeptide receptor agonist improves the gastrointestinal tolerability of glucagon-like peptide-1 receptor agonist therapy. Diabetes, obesity & metabolism (2024)
Karen Schneck, Shweta Urva
Population pharmacokinetics of the GIP/GLP receptor agonist tirzepatide. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Karen Schneck, Shweta Urva
Population pharmacokinetics of the GIP/GLP receptor agonist tirzepatide. CPT: pharmacometrics & systems pharmacology 13 (3) (2024)
Shweta Urva, Joshua A Levine, Karen Schneck, Cheng Cai Tang
Model-based simulation of glycaemic effect and body weight loss when switching from semaglutide or dulaglutide to once weekly tirzepatide. Current medical research and opinion (2024)
Shweta Urva, Libbey O'Farrell, Yu Du, Mei Teng Loh, Andrea Hemmingway, Hongchang Qu, Jorge Alsina-Fernandez, Axel Haupt, Zvonko Milicevic, Tamer Coskun
The novel GIP, GLP-1 and glucagon receptor agonist retatrutide delays gastric emptying. Diabetes, obesity & metabolism (2023)
Shweta Urva, Tonya Quinlan, John Landry, Xiaosu Ma, Jennifer A Martin, Charles T Benson
Effects of Hepatic Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide. Clinical pharmacokinetics 61 (7) (2022)
Shweta Urva, Tonya Quinlan, John Landry, Jennifer Martin, Corina Loghin
Effects of Renal Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide. Clinical pharmacokinetics 60 (8) (2021)
Kenichi Furihata, Hanaka Mimura, Shweta Urva, Tomonori Oura, Shweta Urva, Takeshi Imaoka
A phase 1 multiple-ascending dose study of tirzepatide in Japanese participants with type 2 diabetes. Diabetes, obesity & metabolism (2021)
Shweta Urva, Tamer Coskun, Corina Loghin, Xuewei Cui, Emily Beebe, Libbey O'Farrell, Daniel A Briere, Charles Benson, Michael A Nauck, Axel Haupt
The novel dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide transiently delays gastric emptying similarly to selective long-acting GLP-1 receptor agonists. Diabetes, obesity & metabolism 22 (10) (2020)